Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000032846Phase 4Not yet recruiting
Phase 4, randomised, single-blind trial of remimazolam (2 arms), sponsored by Sichuan Bayi Rehabilitation Center. Primary endpoints: Vital signs, Bispectral Index and 1 more. Planned start Jun 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000032846.